CellSource Co., Ltd.

4880・Standard Market・Pharmaceuticals

Official website

CellSource Co., Ltd.

4880・Standard Market・Pharmaceuticals

Official website

CellSource Co., Ltd.4880

Reference Indicators

Market Cap

66¥100M

P/E (Forecast)

—

P/B

1.1x

Dividend Yield (Forecast)

0.00%

ROE

0.2%

EV/EBITDA

5.2x

Financial Summary

Unit: ¥M

Item	2021Oct 2021	2022Oct 2022	2023Oct 2023	2024Oct 2024	2025Oct 2025
Net Sales	2,922	4,273	4,510	4,355	3,711
Cost of Sales	848	1,209	1,325	1,937	1,623
Gross Profit	2,074	3,064	3,185	2,417	2,087
SG&A Expenses	1,081	1,493	1,963	2,288	1,920
Operating Income	992	1,571	1,221	129	166
Non-operating Income	20	25	29	124	15
Non-operating Expenses	6	12	56	17	14
Ordinary Income	1,006	1,583	1,194	236	167
Extraordinary Income	—	—	45	58	6
Extraordinary Losses	—	—	—	—	64
Pre-tax Income	1,006	1,583	1,239	294	109
Income Taxes	354	565	316	57	99
Net Income	651	1,017	923	237	10
EBITDA	1,022	1,616	1,285	271	364
Gross Margin	71.0%	71.7%	70.6%	55.5%	56.2%
Operating Margin	34.0%	36.8%	27.1%	3.0%	4.5%
ROA	19.4%	22.1%	13.4%	3.4%	0.2%
ROE	27.5%	31.6%	18.7%	3.9%	0.2%